Metipranolol ophthalmic Interactions
There are 215 drugs known to interact with metipranolol ophthalmic, along with 9 disease interactions. Of the total drug interactions, 27 are major, 179 are moderate, and 9 are minor.
- View all 215 medications that may interact with metipranolol ophthalmic
- View metipranolol ophthalmic disease interactions (9)
Most frequently checked interactions
View interaction reports for metipranolol ophthalmic and the medicines listed below.
- Activated Charcoal (charcoal)
- Aspir 81 (aspirin)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Dextrose (glucose)
- Dilantin (phenytoin)
- Diltiazem Hydrochloride SR (diltiazem)
- GlipiZIDE XL (glipizide)
- Glycerol (glycerin)
- Iodides (sodium iodide)
- Janumet (metformin / sitagliptin)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Levaquin (levofloxacin)
- Lipitor (atorvastatin)
- Lithium Carbonate ER (lithium)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Plavix (clopidogrel)
- Quercetin (bioflavonoids)
- Valproate Sodium (valproic acid)
- Valturna (aliskiren / valsartan)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
Metipranolol ophthalmic disease interactions
There are 9 disease interactions with metipranolol ophthalmic which include:
- asthma/COPD
- bradycardia/AV block
- cardiogenic shock
- CHF
- diabetes
- hypersensitivity
- hyperthyroidism
- PVD
- myasthenia gravis
More about metipranolol ophthalmic
- metipranolol ophthalmic consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.